Hyloris secures €6M debt package to extend runway into 2027

What's the deal? Belgian pharmaceutical company Hyloris has secured a €6 million financing package, the Liège-based firm said on Wednesday evening. The round is structured as post-IPO debt.

Why now? Hyloris reported €8.7 million in cash at the end of June 2026 and remained loss-making, though its first-half net loss narrowed to €1.9 million. The new package adds flexibility rather than signalling a turnaround.

What's the endgame? The money gives Hyloris room to fund its product pipeline and commercial activity. The company had previously said CEO support would extend its cash runway into the fourth quarter of 2027.

The signal: The package marks a step up from Hyloris's previous round, giving the company fresh breathing room as it works to narrow losses and build out its commercial business.

Read more: tijd.be

Image credit: Generated with Gemini